Simon M Ametamey Selected Research

Brain-Derived Neurotrophic Factor (BDNF)

10/2019

Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep-wake cycle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon M Ametamey Research Topics

Disease

30	Neoplasms (Cancer) 10/2021 - 10/2004
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2013
7	Atherosclerotic Plaque (Atheroma) 04/2017 - 03/2006
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2012
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022 - 09/2013
4	Tobacco Use Disorder (Nicotine Dependence) 11/2019 - 01/2013
3	Nervous System Diseases (Neurological Disorders) 11/2019 - 05/2012
3	Neuroinflammatory Diseases 01/2019 - 03/2015
3	Inflammation (Inflammations) 01/2015 - 04/2012
3	Rupture 08/2014 - 06/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2014 - 04/2012
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2018
2	Sleep Deprivation 10/2019 - 01/2013
2	Atherosclerosis 04/2017 - 01/2013
2	Schizophrenia (Dementia Praecox) 01/2017 - 05/2012
2	Infections 01/2016 - 10/2004
2	Brain Diseases (Brain Disorder) 05/2015 - 05/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2014 - 01/2013
2	Multiple Sclerosis 03/2014 - 09/2013
2	Osteosarcoma (Osteogenic Sarcoma) 08/2013 - 03/2006
2	Major Depressive Disorder (Major Depressive Disorders) 01/2013 - 07/2011
2	Abscess 03/2006 - 03/2004
2	Soft Tissue Infections 10/2004 - 03/2004
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2022
1	Stroke (Strokes) 01/2022
1	Mood Disorders (Mood Disorder) 10/2020
1	Bulimia Nervosa 01/2020
1	Dementia (Dementias) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Alcoholism (Alcohol Abuse) 10/2018
1	Huntington Disease (Huntington's Disease) 02/2018
1	Insulinoma 01/2018
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016
1	Cognitive Dysfunction 04/2015
1	Shock 03/2015

Drug/Important Bio-Agent (IBA)

12	Folic Acid (Vitamin M)FDA LinkGeneric 10/2021 - 07/2006
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022 - 01/2019
8	Metabotropic Glutamate 5 ReceptorIBA 01/2020 - 07/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2010
5	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 05/2010
5	Biological ProductsIBA 02/2018 - 01/2013
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018 - 03/2014
4	Tyrosine (L-Tyrosine)FDA Link 01/2016 - 01/2013
4	Tryptophan (L-Tryptophan)FDA Link 01/2016 - 03/2012
4	Amino Acids FDA Link 01/2016 - 03/2012
4	AcidsIBA 01/2014 - 07/2006
4	BombesinIBA 10/2013 - 09/2008
4	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 08/2010
3	Pharmaceutical PreparationsIBA 11/2019 - 03/2006
3	Nicotine FDA Link 11/2019 - 01/2013
3	Peptides (Polypeptides)IBA 01/2018 - 02/2011
3	SiliconIBA 01/2018 - 09/2008
3	RadiopharmaceuticalsIBA 01/2016 - 04/2012
3	(18F)fluoroethyltyrosineIBA 01/2016 - 01/2013
3	CB2 Cannabinoid ReceptorIBA 05/2015 - 09/2013
3	fluoromisonidazoleIBA 08/2013 - 07/2005
3	Bombesin Receptors (Bombesin Receptor)IBA 02/2011 - 09/2008
2	CannabinoidsIBA 10/2022 - 09/2013
2	Fluorine-18IBA 01/2020 - 01/2013
2	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2020 - 08/2009
2	LipopolysaccharidesIBA 01/2019 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 01/2015
2	ApolipoproteinsIBA 04/2017 - 04/2015
2	Protein Isoforms (Isoforms)IBA 01/2016 - 04/2012
2	AlbuminsIBA 01/2016 - 12/2013
2	Aromatic-L-Amino-Acid DecarboxylasesIBA 01/2016 - 03/2012
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2006 - 10/2004
2	fluoromethylcholineIBA 03/2006 - 03/2004
1	Ketamine FDA LinkGeneric 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	5,11-methenyltetrahydrohomofolateIBA 10/2021
1	Folate Receptor 1IBA 04/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	AminesIBA 11/2019
1	PSS232IBA 11/2019
1	Protons (Proton)IBA 10/2019
1	gamma-Aminobutyric Acid (GABA)IBA 10/2019
1	Glutamine (L-Glutamine)FDA Link 10/2019
1	Glutathione (Reduced Glutathione)IBA 10/2019
1	Choline (Choline Chloride)IBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	N-acetylaspartate (N-acetyl aspartate)IBA 10/2019
1	LigandsIBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2018
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	Apolipoproteins E (ApoE)IBA 04/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	EnzymesIBA 01/2016
1	EndocannabinoidsIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 04/2015
1	NitrogenIBA 03/2015
1	fibroblast activation protein alphaIBA 01/2015

Therapy/Procedure

9	Therapeutics 10/2021 - 10/2004